Curifylabs Unveils Next Gen 3D Printer for Scalable Plug-And-Play Pharmaceutical Compounding
PharmaPrinter Aurum streamlines pharmacy workflows with enhanced speed, simplified cleaning, and a modern, compact design CurifyLabs today announced the rollout of its latest innovation in compounding pharmacy technology, the CurifyLabs PharmaPrinter Aurum. The newest evolution of the CurifyLabs Compounding System Solution (CSS), Aurum is an advanced compounding 3D printer designed to modernize, streamline, and accelerate the preparation […]
The Medicine Maker Presents CurifyLabs PharmaPrinter Aurum
Meet PharmaPrinter Aurum — our newest launch, presented by the Medicine Maker himself! We recently officially introduced PharmaPrinter Aurum, the next step forward in automated pharmaceutical compounding and production. But instead of just reading a press release… why not see it in action? In the latest episode of our YouTube series The Medicine Maker, our […]
PharmaComplete Technology Solutions Launches Apollo & Onyx
HealthWell Foundation Publishes 2025 Preliminary Results of Operations
Over Half a Billion Dollars in Financial Support Received & More Than a Billion Dollars in Assistance Provided to Patients The HealthWell Foundation®, an independent non-profit charitable organization that provides financial assistance for underinsured Americans, has published preliminary results of its 2025 operations. The 2025 Year in Review highlights the $530 million* in financial support HealthWell received from […]
Nimble and DigitalRx Partnership
Better Patient Care, Less Busywork; Nimble And DigitalRX Are Partnering To Give Independent Pharmacies Both Nimble and DigitalRx have officially partnered — and the result is something independent pharmacies have long needed: a connected platform that makes it easier to deliver great patient care without piling more work onto your staff. DigitalRx brings the PMS […]
ProRx Pharma Continues to Grow Operational Footprint, Triples Production Capacity to Support Demand for Compounded Medications
ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced a period of significant growth, including increased production capacity, a larger facility footprint, and expanded delivery capabilities into two new states, Oklahoma and Virginia, with additional states expected in the coming months. Read More >
XiFin Announces Empower AI RCM Ecosystem to Redefine How Healthcare Revenue Operations Scale
Launches suite of AI capabilities that deliver improved performance across RCM workflows; Northwell Health to share real-world ROI at HIMSS 2026 XiFin, Inc., a leader in revenue cycle management (RCM) solutions, today announced XiFin® Empower AI, an interoperable, intelligent AI RCM ecosystem designed to coordinate AI, automation, and agentic workflows across healthcare revenue operations. Built on XiFin’s […]
Longevity Is No Longer Fringe Medicine. It’s Operational Medicine.
Longevity medicine was once treated as a niche. It showed up in performance-focused settings, but not in structured clinical care. That has changed. Today, aging biology, metabolic health, hormone physiology, and cellular function are active areas of institutional research. Organizations such as the National Institute on Aging, part of the National Institutes of Health, support ongoing study […]
XiFin Introduces Empower AI for Specialty Pharmacy at Asembia AXS26 and Unveils New Specialty Pharmacy Research Findings
New AI-driven RCM capabilities address rising reimbursement complexity, with new Specialty Pharmacy Transformation survey findings underscoring growing demand for intelligent automation XiFin, Inc., a leader in AI-driven revenue cycle management (RCM) solutions, today announced the introduction of XiFin® Empower AI for Specialty Pharmacy at Asembia’s AXS26 Summit (booth #1909), delivering a new approach to managing the growing complexity […]
PHASE Scientific Announces U.S. FDA CLIA Waiver for FebriDx®
PHASE Scientific, the exclusive U.S. distributor of FebriDx® under its previously announced distribution agreement with Lumos Diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted a Clinical Laboratory Improvement Amendments (CLIA) waiver for FebriDx®, following the test’s 510(k) clearance (K260787). The CLIA waiver materially expands the settings in which FebriDx can […]
